TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ALXO

Alx Oncology Holdings 

Healthcare · Biotechnology

1.20$ -6.2% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Alx Oncology Holdings  (ALXO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 161 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ALXO
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
220 243 213 215 186 148 121 95 83 59 178 161
199 189 168 169 156 134 103 85 67 51 146 143
20 22 14 16 16 18 21 19 23 16 32 23
190 183 157 157 149 128 98 79 61 45 140 138
0.6 1.0 1.1 6.2 1.2 0.9 0.9 0.7 – 0.3 – –
-7.0 – – – 0.0 – – – – – – –
51 53 48 55 49 34 33 31 38 33 27 25
35 36 32 38 32 19 19 19 28 25 20 15
1.6 1.6 1.8 1.7 – 0.4 1.7 5.1 4.3 5.2 5.2 –
13 8.6 6.2 8.1 7.9 4.5 3.9 4.9 6.6 4.9 3.9 3.0
9.6 9.6 9.7 9.8 9.8 9.5 8.2 7.0 5.8 4.5 3.3 9.7
169 190 164 159 137 114 88 64 45 26 151 136
-441 -486 -522 -561 -592 -621 -652 -678 -700 -723 -741 -759
41 49 50 52 53 53 53 53 54 54 105 136

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?